Monday, December 30, 2019

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer The drug is now the only approved medicine in biomarker-selected patients with advanced pancreatic cancer.

from Moneycontrol Business News https://ift.tt/35awRrv

No comments:

Post a Comment

Stocks in news: Trent, BPCL, Bajaj Finance, Mankind Pharma, Apollo Tyres

Indian markets surged on Tuesday, buoyed by a significant trade pact with the US. The Nifty's strong rebound suggests a potential trend ...